{"data":[{"accessionNo":"0002100119-26-001562","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical Inc","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":1621026,"percentOfClass":4.97,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0000769734-26-000057","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":"19459J104","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"PRINCIPAL GLOBAL INVESTORS","reportingCik":null,"personType":"IA","sharesOwned":1514310,"percentOfClass":4.7,"filedAt":"2026-10-29","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-114760","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":2400985,"percentOfClass":7.4,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-114760","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2400985,"percentOfClass":7.4,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-114760","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2400985,"percentOfClass":7.4,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-114760","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1897471,"percentOfClass":5.8,"filedAt":"2026-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-100342","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-08-17","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1820330,"percentOfClass":5.6,"filedAt":"2026-08-24","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-100342","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-08-17","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1820330,"percentOfClass":5.6,"filedAt":"2026-08-24","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-100342","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-08-17","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1820330,"percentOfClass":5.6,"filedAt":"2026-08-24","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-100342","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-08-17","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1769122,"percentOfClass":5.4,"filedAt":"2026-08-24","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001941040-26-000630","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Fuller & Thaler Asset Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":1632780.71,"percentOfClass":5.03,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0000769734-26-000038","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":"19459J104","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"PRINCIPAL GLOBAL INVESTORS","reportingCik":null,"personType":"IA","sharesOwned":1632360,"percentOfClass":5,"filedAt":"2026-08-05","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0002100119-26-001318","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical Inc","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":1625821,"percentOfClass":5.01,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001274173-26-000123","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":1825651,"percentOfClass":5.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001580642-26-003195","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Finny Kuruvilla, M.D. Ph. D.","reportingCik":null,"personType":"HC,IN","sharesOwned":1424282,"percentOfClass":4.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001580642-26-003195","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Eventide Asset Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":1424282,"percentOfClass":4.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001580642-26-003195","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Robin C. John","reportingCik":null,"personType":"HC,IN","sharesOwned":1424282,"percentOfClass":4.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001037389-26-000035","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":"19459J104","securityClass":"Common stock","eventDate":"2026-01-08","reportingPerson":"Renaissance Technologies Holdings Corporation","reportingCik":null,"personType":"HC","sharesOwned":1469449,"percentOfClass":4.53,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001037389-26-000035","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":"19459J104","securityClass":"Common stock","eventDate":"2026-01-08","reportingPerson":"Renaissance Technologies LLC","reportingCik":null,"personType":"IA","sharesOwned":1469449,"percentOfClass":4.53,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-059548","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-07","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1519500,"percentOfClass":4.7,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-059548","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-07","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1519500,"percentOfClass":4.7,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-059548","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-07","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1519500,"percentOfClass":4.7,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-059548","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-07","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1515406,"percentOfClass":4.7,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0000914208-26-000184","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical Inc","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Invesco Ltd.","reportingCik":null,"personType":"HC,IA","sharesOwned":1591909,"percentOfClass":5,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0000102909-26-001097","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical Inc","ticker":"COLL","cusip":"19459J104","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001580642-26-001061","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceuticals, Inc.","ticker":"COLL","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Finny Kuruvilla, M.D. Ph. D.","reportingCik":null,"personType":"HC,IN","sharesOwned":1876239,"percentOfClass":5.9,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001580642-26-001061","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceuticals, Inc.","ticker":"COLL","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Eventide Asset Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":1876239,"percentOfClass":5.9,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001580642-26-001061","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceuticals, Inc.","ticker":"COLL","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Robin C. John","reportingCik":null,"personType":"HC,IN","sharesOwned":1876239,"percentOfClass":5.9,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-015179","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Rubric Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1496436,"percentOfClass":4.73,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001104659-26-015179","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001267565","issuerName":"Collegium Pharmaceutical, Inc.","ticker":"COLL","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"David Rosen","reportingCik":null,"personType":"HC,IN","sharesOwned":1496436,"percentOfClass":4.73,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001037389-25-000067","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-08","reportingPerson":"Renaissance Technologies Holdings Corporation","reportingCik":null,"personType":"HC","sharesOwned":1599189,"percentOfClass":5.06,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/coll"},{"accessionNo":"0001037389-25-000067","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001267565","issuerName":"COLLEGIUM PHARMACEUTICAL, INC","ticker":"COLL","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-08","reportingPerson":"Renaissance Technologies LLC","reportingCik":null,"personType":"IA","sharesOwned":1599189,"percentOfClass":5.06,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/coll"}],"updatedAt":"2026-11-05T15:21:01.531Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/coll","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}